MedTrace Logo

Routine Or Selective Stress Testing After Revascularization: ROSSTAR Trial RCT Outline

NCT03067402 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1100

Last updated 2017-03-16

No results posted yet for this study

Summary

The ROSSTAR trial is a pragmatic trial that will directly compare the strategies of routine and selective stress imaging testing (with radionuclide imaging (RNI)) late after PCI or CABG in asymptomatic patients. The study will be a single center trial based at the Jewish General Hospital (JGH), a McGill University teaching hospital (Montreal, Quebec). A total of 1100 patients who are either \>5 years post-CABG or \>2 years post-PCI will be randomized. Half of the patients will be randomized to a routine RNI testing, and the other half to selective RNI testing.

Conditions

Interventions

OTHER

Observation

Patient receives standard observation i.e. only do a nuclear imaging stress test if symptoms present themselves over the course of 3 years

DIAGNOSTIC_TEST

Nuclear Perfusion Imaging Stress Test

Patient receives routine nuclear image perfusion stress test

Sponsors & Collaborators

  • Sir Mortimer B. Davis - Jewish General Hospital

    lead OTHER

Principal Investigators

  • Dominique Joyal, MD · Interventional Cardiologist, Assistant Professor of Medicine, McGill University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-20
Primary Completion
2021-06-20
Completion
2022-06-10

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03067402 on ClinicalTrials.gov